4 ways to shoot down skyrocketing drug prices
by HALEY SWEETLAND EDWARDS
Oct 15, 2016
3 minutes
WHEN POLITICIANS DECRIED the drug company Mylan’s decision to increase the price of an EpiPen by 500% in less than six years, their indignation rang familiar. After all, Congress had just wrapped up a series of hearings examining Valeant Pharmaceuticals’ decision to raise the price of a single vial of its heart medication Isuprel from $180 to $1,472. A few months earlier, Turing Pharmaceuticals CEO Martin Shkreli had been deemed the “most hated man in America” after increasing the price of the antiparasitic drug Daraprim by 5,000% in one month, from
You’re reading a preview, subscribe to read more.
Start your free 30 days